Company Filing History:
Years Active: 2022
Title: Bharat Shimpukade: Innovator in GPR120 Modulation
Introduction
Bharat Shimpukade is a notable inventor based in Bengaluru, India. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that modulate G-protein-coupled receptors.
Latest Patents
Shimpukade holds a patent for "Tetrahydro-benzo[d]azepine derivatives as GPR120 modulators." This patent describes novel tetrahydroisoquinoline and tetrahydrobenzazepine compounds capable of modulating the GPR120 receptor. These compounds are designed for use in controlling insulin levels in vivo and for treating conditions such as diabetes, inflammation, obesity, and metabolic diseases. He has 1 patent to his name.
Career Highlights
Bharat Shimpukade is currently associated with Caldan Therapeutics Limited, where he continues to innovate in the field of drug development. His work focuses on creating effective therapeutic solutions for metabolic disorders.
Collaborations
Some of his notable coworkers include Jane Theresa Brown and Stephen Connolly, who contribute to the collaborative efforts at Caldan Therapeutics Limited.
Conclusion
Bharat Shimpukade's work in GPR120 modulation represents a significant advancement in the treatment of metabolic diseases. His innovative approach and dedication to research continue to impact the pharmaceutical industry positively.